Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.
Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.
Ultragenyx appoints independent director
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.
Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.